We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$297M
AUM Growth
-$1.65M
Cap. Flow
-$9.01M
Cap. Flow %
-3.03%
Top 10 Hldgs %
78.87%
Holding
71
New
6
Increased
2
Reduced
Closed
8

Top Sells

Rank Stock Value
1
AVDX
AvidXchange
AVDX
+$33.7M
2
PAYO icon
Payoneer
PAYO
+$3.92M
3
SQSP
Squarespace, Inc.
SQSP
+$3.08M
4
PCOR icon
Procore
PCOR
+$869K
5
RKLB icon
Rocket Lab Corp
RKLB
+$360K

Sector Composition

Rank Sector Weight
1 Technology 59.52%
2 Consumer Discretionary 18.38%
3 Healthcare 12.94%
4 Communication Services 2.98%
5 Energy 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QS icon
51
QuantumScape Corp
QS
$3.21B
$237K 0.08%
28,951
DASH icon
52
DoorDash
DASH
$85.5B
$159K 0.05%
2,505
RLYB icon
53
Rallybio
RLYB
$84.5M
$125K 0.04%
2,735
RPTX
54
DELISTED
Repare Therapeutics
RPTX
$121K 0.04%
12,276
IPSC icon
55
Century Therapeutics
IPSC
$364M
$101K 0.03%
29,018
RYTM icon
56
Rhythm Pharmaceuticals
RYTM
$6.81B
$101K 0.03%
+5,639
New +$142K
OPEN icon
57
Opendoor
OPEN
$3.64B
$82.2K 0.03%
48,264
ASTR
58
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$79.3K 0.03%
12,444
LOV
59
DELISTED
Spark Networks SE American Depositary Shares
LOV
$69.8K 0.02%
104,228
PMVP icon
60
PMV Pharmaceuticals
PMVP
$59.2M
$55K 0.02%
11,533
GRNA
61
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$21.1K 0.01%
48,835
ALGS icon
62
Aligos Therapeutics
ALGS
$26.2M
$16.4K 0.01%
751
NXTC icon
63
NextCure
NXTC
$16.8M
$14.9K 0.01%
837
AVDX
64
DELISTED
AvidXchange
AVDX
-3,387,792
Closed -$33.7M
LZ icon
65
LegalZoom.com
LZ
$1.35B
-45,767
Closed -$354K
PAYO icon
66
Payoneer
PAYO
$2.42B
-717,416
Closed -$3.92M
PCOR icon
67
Procore
PCOR
$8.26B
-18,414
Closed -$869K
RKLB icon
68
Rocket Lab Corp
RKLB
$40.6B
-95,416
Closed -$360K
SQSP
69
DELISTED
Squarespace, Inc.
SQSP
-138,839
Closed -$3.08M
DCT
70
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
-14,508
Closed -$175K
RUBY
71
DELISTED
Rubius Therapeutics, Inc
RUBY
-986,878
Closed -$173K

Similar funds

Harbourvest Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Harbourvest Partners held 71 positions worth $297M, down 0.55% from $299M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Harbourvest Partners withdrew a net $9.01M in Q1 2023, closing 8 positions. Its most notable exit was AvidXchange, an estimated $33.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 60% of assets, down from 66% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Harbourvest Partners opened a new position in Hesai Group worth $9.38M.

  • Harbourvest Partners's largest Q1 2023 buy was Hesai Group: 606,061 shares worth $9.38M.
  • Harbourvest Partners added most to Omega Therapeutics, Inc. Common Stock in Q1 2023, an estimated $6.02M increase.
  • Harbourvest Partners fully exited AvidXchange in Q1 2023, selling an estimated $33.7M.
  • Harbourvest Partners's ten largest holdings make up 79% of its $297M portfolio in Q1 2023.
  • Harbourvest Partners opened 6 new positions and closed 8 in Q1 2023.
  • Harbourvest Partners's portfolio value fell 0.55% quarter-over-quarter to $297M.

Based on Harbourvest Partners's 13F filing for Q1 2023, filed 15 May 2023.